Is this you? Create Your Porfile
Avatar

Dorothy S. Slusarchyk

Princeton University

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Dorothy S. Slusarchyk is active.

Explore More

Publication

Featured researches published by Dorothy S. Slusarchyk.

Cellular and Molecular Life Sciences | 1982

Activity of sulfa drugs and dihydrofolate reductase inhibitors againstCandida albicans

Karen Bush; Joan S. Freudenberger; Dorothy S. Slusarchyk; Richard B. Sykes; Edward Meyers

Growth ofCandida albicans can be inhibited by sulfa drugs which prevent biosynthesis of folic acid. The dihydrofolate reductase (E.C. 1.5.1.3) inhibitors aminopterin and methotrexate also exhibit anticandidal activity, but trimethoprim does not. Kinetic evaluations withC. albicans dihydrofolate reductase indicate that methotrexate and aminopterin are tight-binding inhibitors whereas trimethoprim binds poorly.

The Journal of Antibiotics | 1984

Muraceins - Muramyl peptides produced by Nocardia orientalis as angiotensin-converting enzyme inhibitors I. Taxonomy, fermentation and biological properties.

Karen Bush; Paul R. Henry; Dorothy S. Slusarchyk

The Journal of Antibiotics | 1970

Isolation,characterization,and structure of rabelomycin,a new antibiotic

Wen-Chih Liu; William L. Parker; Dorothy S. Slusarchyk; Gail L. Greenwood; Susan F. Graham; Edward Meyers

The Journal of Antibiotics | 1978

IONOMYCIN, A NEW POLYETHER ANTIBIOTIC

Wen-Chin Liu; Dorothy S. Slusarchyk; Gail L. Astle; William H. Trejo; William E. Brown; Edward Meyers

The Journal of Antibiotics | 1987

XYLOCANDIN: A NEW COMPLEX OF ANTIFUNGAL PEPTIDES

Edward Meyers; G. S. Bisacchi; Loretta Dean; Wen-Chin Liu; B. Minassian; Dorothy S. Slusarchyk; Richard B. Sykes; S. K. Tanaka; William H. Trejo

The Journal of Antibiotics | 1984

Phenacein--an angiotensin-converting enzyme inhibitor produced by a streptomycete. I. Taxonomy, fermentation and biological properties.

Karen Bush; Paul R. Henry; Margaret Souser-Woehleke; William H. Trejo; Dorothy S. Slusarchyk

The Journal of Antibiotics | 1985

Catacandins, novel anticandidal antibiotics of bacterial origin

Dward Meyers; Raymond Cooper; Loretta Dean; Janice H. Johnson; Dorothy S. Slusarchyk; William H. Trejo; Pushpa D. Singh

The Journal of Antibiotics | 1970

Janiemycin,a new peptide antibiotic

Edward Meyers; Frank Lee Weisenborn; Felix Pansy; Dorothy S. Slusarchyk; Malcolm H. Von Saltza; Marlene L. Rathnum; William L. Parker

The Journal of Antibiotics | 1973

EM49, a new peptide antibiotic. 3. biological characterization in vitro and in vivo.

Edward Meyers; Felix Edward Pansy; Harold I. Basch; Ronald J. Mcripley; Dorothy S. Slusarchyk; Susan F. Graham; William H. Trejo

Archive | 1983

Phenazine ACE inhibitor produced from streptomyces species

Karen Bush; Dorothy S. Slusarchyk; Wen-Chih Liu

Explore More

Collaboration

Dive into the Dorothy S. Slusarchyk's collaboration.

Top Co-Authors
Avatar

Edward Meyers

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Karen Bush

Kosan Biosciences

View shared research outputs
Top Co-Authors
Avatar

William H. Trejo

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Wen-Chih Liu

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Loretta Dean

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Pushpa D. Singh

Princeton University

View shared research outputs
Top Co-Authors
Avatar

Richard B. Sykes

Princeton University

View shared research outputs
Top Co-Authors
Avatar

William L. Parker

Princeton University

View shared research outputs
Top Co-Authors
Avatar

Dward Meyers

Schering-Plough

View shared research outputs
Top Co-Authors
Avatar

Felix Edward Pansy

Princeton University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge